top of page

The voice of Colville and northeastern Washington since 1896

|

September 15, 2026

COLVILLE, WA

58°F

Chance Light Rain

About
Contact
Place an Ad
Submissions
Freelance Opportunities
Join Our Team

LETTERS TO THE EDITOR

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Bio-Rad Laboratories, Inc. Class A Common Stock (NY:BIO)

380.81 -0.19 (-0.05%)

Streaming Delayed Price Updated: 2:36 PM EDT, Sep 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bio-Rad Laboratories, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO ↗

August 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)...

Via Benzinga

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO ↗

August 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

Stocks That Hit 52-Week Highs On Thursday ↗

July 29, 2021

Thursday's morning session saw 167 companies set new 52-week highs. Points of Interest: ASML Holding (NASDAQ:ASML) was the largest company by market cap to set a new...

Via Benzinga

The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal ↗

July 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc...

Via Benzinga

The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings ↗

August 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business ↗

August 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs ↗

July 30, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Bio-Rad Laboratories, inc (BIO) Q2 2021 Earnings Call Transcript ↗

July 30, 2021

BIO earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Recap: Bio-Rad Laboratories Q2 Earnings ↗

July 29, 2021

Shares of Bio-Rad Laboratories (NYSE:BIO) moved higher by 0.2% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 119.88%...

Via Benzinga

Bio-Rad Reports Second-Quarter 2021 Financial Results

July 29, 2021

From Bio-Rad Laboratories, Inc.

Via Business Wire

The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs ↗

July 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Bio-Rad and 10x Genomics Announce Settlement to Resolve Multiple Litigations

July 27, 2021

From Bio-Rad Laboratories, Inc.

Via Business Wire

The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More ↗

July 25, 2021

Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start...

Via Benzinga

Stocks That Hit 52-Week Highs On Tuesday ↗

July 27, 2021

This morning 85 companies set new 52-week highs. Noteworthy Mentions: The largest company by market cap to set a new 52-week high was Alphabet (NASDAQ:GOOG). Intec...

Via Benzinga

Bio-Rad to Report Second-Quarter 2021 Financial Results, Thursday, July 29, 2021

July 14, 2021

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio-Rad Announces Partnership with Seegene for Molecular Diagnostic Testing Products

June 30, 2021

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio-Rad Launches Its PREvalence ddPCR SARS-CoV-2 Wastewater Quantification Kit for COVID-19 Wastewater Testing

June 21, 2021

From Bio-Rad Laboratories, Inc.

Via Business Wire

5 Value Stocks To Watch In The Healthcare Sector ↗

June 14, 2021

What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...

Via Benzinga

The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test ↗

July 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7) Ambrx Biopharma Inc. (NYSE:...

Via Benzinga

Topics Product Recall

Bio-Rad to Participate at Jefferies Virtual Healthcare Conference

May 20, 2021

From Bio-Rad Laboratories, Inc.

Via Business Wire

5 Value Stocks In The Healthcare Sector ↗

May 10, 2021

What are Value Stocks? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples...

Via Benzinga

Bio-Rad Laboratories Inc (BIO) Q1 2021 Earnings Call Transcript ↗

April 30, 2021

BIO earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Bio-Rad Reports First-Quarter 2021 Financial Results

April 29, 2021

From Bio-Rad Laboratories, Inc.

Via Business Wire

The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx ↗

April 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:...

Via Benzinga

A Preview Of Bio-Rad Laboratories's Earnings ↗

April 28, 2021

On Thursday, April 29, Bio-Rad Laboratories (NYSE:BIO) will release its latest earnings report. Here is Benzinga's outlook for the company. What Are Earnings, Net Income, And...

Via Benzinga

The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx ↗

April 24, 2021

Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:...

Via Benzinga

Bio-Rad to Report First-Quarter 2021 Financial Results, Thursday, April 29, 2021

April 15, 2021

From Bio-Rad Laboratories, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Local News
Government
Business
Sports
Arts & Entertainment
Farm & Ranch
Great Outdoors
Profiles

Out of the Past
Letters to the Editor
Classifieds
Announcements
Events Calendar
Obituaries
Commissioner Agendas
Superior Court Dockets

Home

About

Contact

Advertising

Legal Notices

Terms of Use

Privacy Policy

Accessibility

Submissions

Place an Ad

Submit an Event

News Tips

Corrections

Letters to the Editor

Freelance Opportunities

Home Delivery

Join our Team

Statesman-Examiner

220 S. Main St.
Colville, WA 99114

Hours: Mon.-Fri., 8 a.m.-5 p.m.

509-684-4567
editor@statesmanexaminer.com

PHOTO GALLERY

Website Designed by Amber S. King – Creative Design

Home
About
Contact
Submissions

About
Contact
Place an Ad
Submissions
Freelance Opportunities
Join Our Team

bottom of page